Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma
Clinical trial NCT03399513 · COMPLETED
Trial details
- NCT number
- NCT03399513
- Sponsor
- University Hospital Muenster
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-03
- Primary completion
- 2023-12-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.